https://www.selleckchem.com/pr....oducts/trastuzumab-d
The ejection fraction during index hospitalization was 58.3±9.7% in the HF with preserved LVEF group, 53.3±10.2% in the HF with mid-range LVEF group, and 43.3±10.5% in the HF with reduced LVEF group (P0.001). The predominant subtypes of HF after AMI were HF with mid-range ejection fraction and preserved ejection fraction, or HF with non-reduced ejection fraction. The predominant subtypes of HF after AMI were HF with mid-range ejection fraction and preserved ejection fraction, or HF with non-reduced ejection fraction.
Like
Comment
Share
